Biblio Discovery — Demo Discovery Service

149 results

Showing 1–20 · 0.24 seconds · RSS

Journal

MMWR Morbidity and Mortality Weekly Report

Scopus

ISSN 0149-2195 · Centers for Disease Control and Prevention · 149 articles in the index

  1. Journal Article Full text

    Treatment for Opioid Use Disorder: Population Estimates — United States, 2022

    Deborah Dowell; Samantha Brown; Shiromani Gyawali et al.

    MMWR Morbidity and Mortality Weekly Report · 2024 · English · OpenAlex Scopus

    In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related and overall mortality. However, only a small proportion of…

  2. Journal Article Full text

    Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024

    Ahmed Jamal; Eunice Y Park-Lee; Jan Birdsey et al.

    MMWR Morbidity and Mortality Weekly Report · 2024 · English · OpenAlex Scopus

    Use of tobacco products in any form is unsafe, and nearly all tobacco product use begins during adolescence.CDC and the Food and Drug Administration (FDA) analyzed data from the 2024 National Youth Tobacco Survey to determine tobacco product use among U.S. middle school (grades 6-8) and high school…

  3. Journal Article Full text

    Tobacco Product Use Among U.S. Middle and High School Students — National Youth Tobacco Survey, 2023

    Jan Birdsey; Monica E. Cornelius; Ahmed Jamal et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Tobacco product use during adolescence increases the risk for lifelong nicotine addiction and adverse health consequences.CDC and the Food and Drug Administration analyzed data from the 2023 National Youth Tobacco Survey to assess tobacco product use patterns among U.S. middle school (grades 6-8)…

  4. Journal Article Full text

    Seasonality of Respiratory Syncytial Virus — United States, 2017–2023

    Sarah Hamid; Amber K. Winn; Rishika Parikh et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    In the United States, respiratory syncytial virus (RSV) infections cause an estimated 58,000-80,000 hospitalizations among children aged

  5. Journal Article Full text

    Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

    Michael Melgar; Amadea Britton; Lauren E. Roper et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Respiratory syncytial virus (RSV) is a cause of severe respiratory illness in older adults. In May 2023, the Food and Drug Administration approved the first vaccines for prevention of RSV-associated lower respiratory tract disease in adults aged ≥60 years. Since May 2022, the Advisory Committee on…

  6. Journal Article Full text

    Prevalence of Adverse Childhood Experiences Among U.S. Adults — Behavioral Risk Factor Surveillance System, 2011–2020

    Elizabeth A. Swedo; Maria Vyshnya Aslam; Linda L. Dahlberg et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Adverse childhood experiences (ACEs) are defined as preventable, potentially traumatic events that occur among persons aged

  7. Journal Article Full text

    Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

    Jefferson M. Jones; Katherine E. Fleming-Dutra; Mila M. Prill et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Respiratory syncytial virus (RSV) is the leading cause of hospitalization among U.S. infants.In July 2023, the Food and Drug Administration approved nirsevimab, a long-acting monoclonal antibody, for passive immunization to prevent RSV-associated lower respiratory tract infection among infants and…

  8. Journal Article Full text

    Provisional Mortality Data — United States, 2022

    Farida B. Ahmad; Jodi A. Cisewski; Jiaquan Xu et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    occurred in the United States. The estimated 2022 age-adjusted death rate decreased by 5.3%, from 879.7 per 100,000 persons in 2021 to 832.8. COVID-19 was reported as the underlying cause or a contributing cause in an estimated 244,986 (7.5%) of those deaths (61.3 deaths per 100,000). The highest…

  9. Journal Article Full text

    Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

    Katherine E. Fleming-Dutra; Jefferson M. Jones; Lauren E. Roper et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Respiratory syncytial virus (RSV) is the leading cause of hospitalization among U.S. infants. Nirsevimab (Bevfortus, Sanofi and AstraZeneca) is recommended to prevent RSV-associated lower respiratory tract infection (LRTI) in infants. In August 2023, the Food and Drug Administration (FDA) approved…

  10. Journal Article Full text

    Tobacco Product Use Among Adults – United States, 2021

    Monica E. Cornelius; Caitlin G. Loretan; Ahmed Jamal et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Commercial cigarette smoking among U.S. adults has declined during the preceding 5 decades (1,2); however, tobacco product use remains the leading cause of preventable disease and death in the United States, and some populations continue to be disproportionately affected by tobacco use (1,2).To…

  11. Journal Article Full text

    Chronic Pain Among Adults — United States, 2019–2021

    S. Michaela Rikard; Andrea E. Strahan; Kristine M Schmit et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Chronic pain (i.e., pain lasting ≥3 months) is a debilitating condition that affects daily work and life activities for many adults in the United States and has been linked with depression (1), Alzheimer disease and related dementias (2), higher suicide risk (3), and substance use and misuse…

  12. Journal Article Full text

    Progress Toward Measles Elimination — Worldwide, 2000–2022

    Anna A. Minta; Matt Ferrari; Sébastien Antoni et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    Measles is a highly contagious, vaccine-preventable disease that requires high population immunity for transmission to be interrupted. All six World Health Organization regions have committed to eliminating measles; however, no region has achieved and sustained measles elimination. This report…

  13. Journal Article Full text

    Nonfatal and Fatal Falls Among Adults Aged ≥65 Years — United States, 2020–2021

    Ramakrishna S. Kakara; Gwen Bergen; Elizabeth R. Burns et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    In the United States, unintentional falls are the leading cause of injury and injury death among adults aged ≥65 years (older adults). Patterns of nonfatal and fatal falls differ by sex and state. To describe this variation, data from the 2020 Behavioral Risk Factor Surveillance System and 2021…

  14. Journal Article Full text

    National, State-Level, and County-Level Prevalence Estimates of Adults Aged ≥18 Years Self-Reporting a Lifetime Diagnosis of Depression — United States, 2020

    Benjamin J. Lee; Yan Wang; Susan A. Carlson et al.

    MMWR Morbidity and Mortality Weekly Report · 2023 · English · OpenAlex Scopus

    regions. Among 3,143 counties, the model-based age-standardized prevalence of depression ranged from 10.7% to 31.9% (median = 21.8%); most of the counties with the highest prevalence were in the Appalachian region, the southern Mississippi Valley region, and Missouri, Oklahoma, and Washington…

  15. Journal Article Full text

    Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

    Jill M. Ferdinands; Suchitra Rao; Brian Edward Dixon et al.

    MMWR Morbidity and Mortality Weekly Report · 2022 · English · OpenAlex Scopus

    Persons categorized as having received 3 doses included those who received a third dose in a primary series or a booster dose after a 2 dose primary series (including the reduced-dosage Moderna booster). The VISION Network analyzed 241,204 ED/UC encounters** and 93,408 hospitalizations across 10…

  16. Journal Article Full text

    Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019

    Nicole D. Ford; Shanna N. Cox; Jean Y. Ko et al.

    MMWR Morbidity and Mortality Weekly Report · 2022 · English · OpenAlex Scopus

    Hypertensive disorders in pregnancy (HDPs), defined as prepregnancy (chronic) or pregnancy-associated hypertension, are common pregnancy complications in the United States.*HDPs are strongly associated with severe maternal complications, such as heart attack and stroke (1), and are a leading cause…

  17. Journal Article Full text

    Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022

    Angela Danielle Iuliano; Joan Brunkard; Tegan K. Boehmer et al.

    MMWR Morbidity and Mortality Weekly Report · 2022 · English · OpenAlex Scopus

    This underscores the importance of national emergency preparedness, specifically, hospital surge capacity and the ability to adequately staff local health care systems. In addition, being up to date on vaccination and following other recommended prevention strategies are critical to preventing…

  18. Journal Article Full text

    Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged

    Catherine E. Barrett; Alain K. Koyama; Pablo Álvarez et al.

    MMWR Morbidity and Mortality Weekly Report · 2022 · English · OpenAlex Scopus

    in addition to chronic disease prevention and management. The mechanism of how SARS-CoV-2 might lead to incident diabetes is likely complex and could differ by type 1 and type 2 diabetes. Monitoring for long-term consequences, including signs of new diabetes, following SARS-CoV-2 infection is…

  19. Journal Article Full text

    Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

    Laura D. Zambrano; Margaret M. Newhams; Samantha M. Olson et al.

    MMWR Morbidity and Mortality Weekly Report · 2022 · English · OpenAlex Scopus

    Multisystem inflammatory syndrome in children (MIS-C) is a severe postinfectious hyperinflammatory condition, which generally occurs 2-6 weeks after a typically mild or asymptomatic infection with SARS-CoV-2, the virus that causes COVID-19 (1-3).In the United States, the BNT162b2 (Pfizer-BioNTech)…

  20. Journal Article

    Adults Meeting Fruit and Vegetable Intake Recommendations — United States, 2019

    Seung Hee Lee; Latetia V. Moore; Sohyun Park et al.

    MMWR Morbidity and Mortality Weekly Report · 2022 · English · OpenAlex Scopus

    and programs that will increase access to fruits and vegetables in places where U.S. residents live, learn, work, and play, might increase consumption and improve health.